SuperworthMicrobot Medical EPS MBOT
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$0.25
- Latest quarter, Q2 FY26
- −$0.08
- Fiscal year 2025
- −$0.30
Microbot Medical's earnings per share was −$0.25 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.08.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.30 | n/a |
| FY2024 | −$0.74 | n/a |
| FY2023 | −$1.09 | n/a |
| FY2022 | n/a | n/a |
| FY2021 | −$1.59 | n/a |
| FY2020 | −$1.29 | −180% |
| FY2019 | $1.61 | −30% |
| FY2018 | $2.30 | −23% |
| FY2017 | $2.98 | −31% |
| FY2016 | $4.35 | n/a |
| FY2015 | −$637.20 | n/a |
| FY2014 | −$891.00 | n/a |
| FY2013 | −$1004.40 | n/a |
| FY2012 | −$1668.60 | n/a |
| FY2011 | −$2413.80 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.08 | n/a | −$0.25 | |
| Q1 FY26 | −$0.05 | n/a | −$0.27 | |
| Q4 FY25 | −$0.05 | n/a | −$0.30 | |
| Q3 FY25 | −$0.07 | n/a | −$0.45 | |
| Q2 FY25 | −$0.10 | n/a | −$0.58 | |
| Q1 FY25 | −$0.08 | n/a | −$0.65 | |
| Q4 FY24 | −$0.20 | n/a | −$0.74 | |
| Q3 FY24 | −$0.20 | n/a | −$0.81 | |
| Q2 FY24 | −$0.17 | n/a | −$0.82 | |
| Q1 FY24 | −$0.17 | n/a | −$0.90 | |
| Q4 FY23 | −$0.27 | n/a | −$1.09 | |
| Q3 FY23 | −$0.21 | n/a | −$1.21 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Microbot Medical's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MBOTMicrobot Medical | −$0.25 | |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| NEPHNephros | $0.16 | +33% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| Peer median | $1.08 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Microbot Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.